Key statistics
On Monday, Resmed Inc (RMD:ASX) closed at 35.74, 11.55% above the 52 week low of 32.04 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 35.75 |
|---|---|
| High | 36.10 |
| Low | 35.60 |
| Bid | 35.74 |
| Offer | 35.87 |
| Previous close | 36.07 |
| Average volume | 1.55m |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
| Annual div (ADY) | 0.3519 AUD |
|---|---|
| Annual div yield (ADY) | 0.98% |
| Div ex-date | Feb 11 2026 |
| Div pay-date | Mar 19 2026 |
Data delayed at least 20 minutes, as of Mar 02 2026 05:10 GMT.
More ▼
- Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
- Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
- Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
- Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
- Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
- Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
- Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
- Resmed Announces Participation in the Bank of America Global Healthcare Conference 2025
- Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
- Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
More ▼
